Advertisement

2012 General Poster Session Abstracts

General Poster Session Abstracts

General Poster Session A  ♦  General Poster Session B


General Poster Session A

 

Communication and Decision-Making
Poster Boards: B3-C9 (Abstracts #3-23)

Involving Patients in Quality Care
Poster Boards: C10-D8 (Abstracts #24-40)

Patient-Reported Outcomes
Poster Boards: D9-E13 (Abstracts #41-63)

Quality Improvement
Poster Boards: E14-K2 (Abstracts #74-161)

Abstract # 65 : A quality improvement program to increase performance with clinical oncology pathways. ( A1 )
Janet L. Espirito , PharmD - The US Oncology Network/ McKesson Specialty Health

Abstract # 285 : Data-driven transformation to an oncology patient-centered medical home. ( A2 )
John David Sprandio , MD - Consultants in Medical Oncology and Hematology

Abstract # 213 : Validation of electronic prostate cancer quality-of-care measures in the Veterans Health Administration (VHA). ( A3 )
Jeremy B. Shelton , MD,MSHS VA Greater Los Angeles Healthcare System; Department of Urology, University of California, Los Angeles

Abstract # 286 : The rapid quality reporting system: Assessing and improving the quality of cancer care with a prospective clinical performance tracking and reporting system. ( A4 )
Erica J. McNamara , MPH - Commission on Cancer, American College of Surgeons

Abstract # 1 : Utilization of intensive care resources due to better communication of end-of-life issues. ( A5 )
Allen Ray Sing Chen , MD, PhD, MHS - The Armstrong Institute for Patient Safety and Quality and The Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University

Abstract # 2 : An IT-integrated, computer-based telephone system for monitoring patient-reported symptoms: Result of two trials. ( A6 )
Kathi Mooney , RN, PhD - University of Utah College of Nursing and Huntsman Cancer Institute

Abstract # 69 : Rates of diagnostic imaging in long-term survivors of young adult malignancies. ( A7 )
Corinne Daly , BSc, MSc - Institute of Medical Science, University of Toronto

Abstract # 70 : Effect of intervention on quality measures of symptom management in the Michigan Oncology Quality Consortium (MOQC). ( A8 )
Jeffrey B. Smerage , MD, PhD - University of Michigain Health System

Abstract # 71 : A Web-based decision support platform to reduce non-evidence-based treatment of non-small cell lung cancer. ( B1 )
Stephen H. Grund , MD, PhD - eviti

Abstract # 10 : Evaluating a preference-tailored decision tool for increasing colorectal cancer screening. ( B10 )
Sarah T. Hawley , PhD, MPH - University of Michigan and Ann Arbor VA Healthcare System

Abstract # 11 : Changes in adjuvant endocrine therapy over one year among postmenopausal women with early-stage breast cancer initiating aromatase inhibitors. ( B11 )
Danielle Lindsay LaMorte , BA - Vanderbilt University School of Medicine

Abstract # 12 : Doctor, what are my options? A prospective cohort study of an individualized care plan for patients with gastrointestinal cancer. ( B12 )
Amanda E. Hird , BSc MD(C) - Division of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, Odette Cancer Centre

Abstract # 13 : Cancer patients’ and physicians’ preferences for decision making regarding pharmacogenomic testing (PGT). ( B13 )
Sinead Cuffe , MD - Princess Margaret Hospital, University of Toronto

Abstract # 14 : Natural language processing (NLP) of Internet conversations to evaluate prostate cancer (PC) patients’ perceptions of active surveillance (AS). ( B14 )
Mark Vikas Mishra , MD - Department of Radiation Oncology, Kimmel Cancer Center, Thomas Jefferson University

Abstract # 72 : The impact of patient navigation on receipt of quality breast cancer treatment in the national patient navigation research program. ( B2 )
Naomi Ko , MD, MPH - Boston University Medical Center

Abstract # 3 : Developing and implementing a balanced scorecard to improve efficiency, cost-effectiveness, and patient experience. ( B3 )
Gerard Colman , FACHE, MHA - The University of Texas MD Anderson Cancer Center

Abstract # 4 : Patient (Pt) and caregiver (Cg) perspectives in non-small cell lung cancer (NSCLC). ( B4 )
Corey J. Langer , MD - Abramson Cancer Center of the University of Pennsylvania

Abstract # 5 : Patient navigation in cancer diagnostics: Providing information and support for more effective care. ( B5 )
Julie Gilbert , MSc, PhD - Cancer Care Ontario

Abstract # 6 : My choices, my wishes: Advance care planning advocacy in the adult oncology population. ( B6 )
Sabrina Q. Mikan , PhD,RN,ACNS-BC - Texas Oncology

Abstract # 7 : Colorectal cancer screening discussions: Maybe 3As is enough? ( B7 )
Jennifer Elston Lafata , PhD - Virginia Commonwealth University

Abstract # 8 : Follow-up of long-term young breast cancer survivors. ( B8 )
Corinne Daly , BSc, MSc - St. Michael's Hospital

Abstract # 9 : Patient understanding and impression of hematology/oncology fellows. ( B9 )
Brendan F. Curley , D.O., M.P.H. - Mary Babb Randolph Cancer Center at West Virginia University

Abstract # 15 : Cost of cancer care: The impact of disclosure on willingness to pay and treatment preferences. ( C1 )
Rebecca Howe , - University of California, San Francisco

Abstract # 24 : Social disparities in perceived coordination of care and use of chemotherapy among patients with stage III colorectal cancer. ( C10 )
Arden M. Morris , MD, MPH - University of Michigan

Abstract # 25 : Access to palliative care before death among patients treated at a comprehensive cancer center. ( C11 )
David Hui , MD, MSc, FRCPC - The University of Texas MD Anderson Cancer Center

Abstract # 26 : Is contralateral prophylactic mastectomy (CPM) overused? Results from a population-based study. ( C12 )
Sarah T. Hawley , PhD, MPH - University of Michigan and Ann Arbor VA Healthcare System

Abstract # 27 : Team training in adult oncology. ( C13 )
Anne Gross , PhD, RN - Dana-Farber Cancer Institute

Abstract # 28 : Outpatient palliative care at a tertiary cancer center: Perceptions, pathways, and pitfalls. ( C14 )
Kavitha Ramchandran , MD - Stanford University

Abstract # 29 : Surgery and chemoradiotherapy in stage II and III esophageal cancer: A retrospective analysis of first-course treatment across different insurances using the NCDB. ( C15 )
Lauren Brin , M3 - Creighton University

Abstract # 30 : Medication therapy management (MTM) in a multidisciplinary supportive oncology clinic. ( C16 )
Robert Mancini , Pharm.D. - St. Luke's Mountain States Tumor Institute

Abstract # 31 : Racial differences in health care utilization in Medicare beneficiaries with metastatic prostate cancer. ( C17 )
Robert A. Bailey , MD - Janssen Scientific Affairs, LLC

Abstract # 32 : Comprehensive and financially sustainable survivorship care. ( C18 )
Alicia R. Rosales , MSW, LCSW, OSW-C - St. Luke's Mountain States Tumor Institute

Abstract # 16 : Avenues to integrate and improve care: Surgeon attitudes toward end-of-life care. ( C2 )
Jonathan Bergman , MD - University of California, Los Angeles Medical Center

Abstract # 17 : Robotic radiosurgery for the treatment of one to three brain metastases: A pragmatic application of cost-benefit analysis using willingness to pay. ( C3 )
Jeffrey Noah Greenspoon , MD - Juravinski Cancer Centre

Abstract # 18 : Impacts of toxicity on patient treatment choices for metastatic breast cancer. ( C4 )
Carol B. White , MBA - Carol B. White & Associates

Abstract # 19 : The future delivery of oncology care: Thoughts on the impact of quality improvement, personalized medicine, and integrating interprofessional collaboration. ( C5 )
Caroline Osborne Robinson , PhD - CE Outcomes, LLC

Abstract # 20 : The impact of “significant others” on breast cancer patients’ treatment decision making. ( C6 )
Suepattra G. May , PhD,MPH - Palo Alto Medical Foundation Research Institute

Abstract # 21 : Physician order for scope of treatment (POST) in South Carolina (SC). ( C7 )
Mark Allen O'Rourke , MD - Greenville Hospital System University Medical Center

Abstract # 22 : Assessment of follow-up decisions and care after BRCA testing. ( C8 )
Sara Sarwar Riaz , MD - Providence Hospital and Medical Centers

Abstract # 23 : Do patients participating in oncology clinical trials understand the informed consent form? A Brown University Oncology Research Group study. ( C9 )
Andrew Schumacher , MSHCE - Rhode Island Hospital

Abstract # 33 : Integration of survivorship care in community oncology practice. ( D1 )
Michele Renee O'Brien , MSN, ACNS-BC, RN, BA - The US Oncology Network/ McKesson Specialty Health

Abstract # 42 : Evaluating the quality of supportive oncology using patient-reported survey data. ( D10 )
Anne M. Walling , MD, PhD - VA Greater Los Angeles Healthcare System

Abstract # 43 : Addressing distress in head and neck cancer patients: A quality improvement project. ( D11 )
Natalie Riblet , MD, MPH - Dartmouth-Hitchcock; Norris Cotton Cancer Center

Abstract # 44 : Oral chemotherapy: A focus on interventions and access. ( D12 )
Robert Mancini , Pharm.D. - St. Luke's Mountain States Tumor Institute

Abstract # 45 : Standards for evaluating patient-reported outcome (PRO)-based performance measures. ( D13 )
Ethan M. Basch , MD, MSc - Memorial Sloan-Kettering Cancer Center

Abstract # 46 : A multicenter, phase IV study of the effectiveness of palliative gemcitabine in patients with advanced pancreatic cancer. ( D14 )
David Wallace , - Queen's University Cancer Research Institute

Abstract # 47 : Creation of On-PROST: The Ontario patient-reported outcomes of symptoms and toxicity applied clinical research unit. ( D15 )
Geoffrey Liu , MD, FRCPC - Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto

Abstract # 48 : Patient-reported oncology readmission factors. ( D16 )
Shreya Kangovi , MD - Philadelphia Veterans Affairs Medical Center

Abstract # 49 : Nomogram predicting treatment-related urinary incontinence for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), or brachytherapy (PI). ( D17 )
Joseph C. Klink , MD - Glickman Urological & Kidney Institute, Cleveland Clinic

Abstract # 50 : How is race/ethnicity associated with patient reporting of cancer pain in recently diagnosed colorectal and lung cancer? ( D18 )
Kathryn Anne Martinez , PhD, MPH - Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management

Abstract # 34 : The potential of a medical student patient navigator program:  An analysis of partners against cancer. ( D2 )
Naomi Whittaker , - Creighton University School of Medicine

Abstract # 35 : Investigating pocket cards to improve cancer patient knowledge of chemotherapy. ( D3 )
Kelly Kevelin Curtis , MD - Mayo Clinic

Abstract # 36 : Barriers to patient accrual in Ontario oncology clinical trials: Attitudes of oncologists and clinical research personnel. ( D4 )
Ammar Bookwala , BSc. (Cand) - St. Michael's Hospital

Abstract # 37 : Early clinical adoption of next-generation sequencing panels for diagnosis of hereditary cancer susceptibility: A single commercial laboratory experience. ( D5 )
Neil M. Barth , MD, FACP - Ambry Genetics

Abstract # 38 : 30-day mortality of surgeries in disseminated cancer patients: An analysis using NSQIP, dividing surgeries into low, medium, and high risk. ( D6 )
Pesavento Anton John , - Creighton University Medical Center, Department of Oncology

Abstract # 39 : Patient experience with service quality: Implications for survival outcomes in prostate cancer. ( D7 )
Christopher G. Lis , MPH - Cancer Treatment Centers of America

Abstract # 40 : Developing a cultural and socioecological patient-centered survivorship care plan template for African American survivors. ( D8 )
Kimlin T. Ashing-Giwa , Ph.D. - City of Hope-Center of Community Alliance for Research & Education

Abstract # 51 : Nomogram predicting treatment-related sexual dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI). ( E1 )
Joseph C. Klink , MD - Glickman Urological & Kidney Institute, Cleveland Clinic

Abstract # 60 : Expanding patient-reported outcomes to oral health complications from systemic cancer therapy. ( E10 )
Rebecca A. Miksad , MD, MPH - Beth Israel Deaconess Medical Center

Abstract # 61 : Effectiveness of HCC treatments in real-world experiences. ( E11 )
Glen I. Misek , - Abbott Laboratories

Abstract # 62 : Four questions: Daily assessment of pain, anxiety, problems or concerns, and need to see physician during a course of radiation therapy. ( E12 )
David D. Howell , MD - University of Michigan Medical School, Department of Radiation Oncology

Abstract # 63 : Key concerns and symptoms of patients undergoing second- and third-line treatment for non-small cell lung cancer: Findings from a patient interview study. ( E13 )
Susan Magasi , PhD - Feinberg School of Medicine, Northwestern University

Abstract # 74 : Development of a quality infrastructure for a 135-site statewide network of community oncologists. ( E14 )
Gay Lindsey , MSN,OCN,RN - Texas Oncology

Abstract # 75 : Developing a comprehensive smoking cessation program in patients with lung cancer: The role of social smoking environments. ( E15 )
Lawson Eng , Hon BSc - Princess Margaret Hospital, University of Toronto

Abstract # 76 : Utilizing network quality committees to improve reporting and adherence to evidence-based clinical pathways. ( E16 )
Debra A. Patt , MD, MPH - Texas Oncology

Abstract # 77 : EMR-linked cancer tracker facilitates lung and liver cancer care. ( E17 )
Tamar H. Taddei , MD - VA Connecticut Healthcare System

Abstract # 78 : Kaizen quality initiative to improve patient satisfaction and throughput in an academic cancer center. ( E18 )
David Dougherty , MD - University of Rochester Medical Center

Abstract # 52 : Associations between receipt of a treatment summary, emotional concerns, and patterns of care among post-treatment cancer survivors. ( E2 )
Ruth Rechis , PhD - LIVESTRONG

Abstract # 53 : Patient-reported outcomes from POINTBREAK: The randomized, open-label, phase III study of pemetrexed (pem) + carboplatin (cb) + bevacizumab (bev) followed by maintenance pem + bev versus paclitaxel (pac) + cb + bev followed by maintenance bev in patients with stage IIIb or IV nonsquamous non-small cell lung cancer (NS-NSCLC). ( E3 )
David R. Spigel , MD - SCRI/Tennessee Oncology, PLLC

Abstract # 54 : High-quality basic care and support needed in lung cancer survivors. ( E4 )
Ping Yang , M.D., Ph.D. - Mayo Clinic

Abstract # 55 : Nomogram predicting treatment-related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI). ( E5 )
Joseph C. Klink , MD - Glickman Urological & Kidney Institute, Cleveland Clinic

Abstract # 56 : Qualitative analysis of practicing oncologists’ attitudes and experiences regarding HIT-facilitated collection of patient-reported outcomes. ( E6 )
Reshma Jagsi , MD, DPhil - Department of Radiation Oncology, University of Michigan Health System

Abstract # 57 : Copayment assistance and adherence to prescription medication among patients with cancer. ( E7 )
Leah L. Zullig , MPH - Department of Health Policy and Management, University of North Carolina at Chapel Hill

Abstract # 58 : Patient-reported outcomes on integrative therapies for pain, tension, and level of comfort. ( E8 )
Kamron Keep , RN, BSN - St. Luke's Mountain States Tumor Institute

Abstract # 59 : Patterns of antidepressant use in patients with cancer: An analysis from SOAPP (E2Z02: Symptom Outcomes and Practice Patterns). ( E9 )
Michael Fisch , MD, MPH - The University of Texas MD Anderson Cancer Center

Abstract # 79 : Development of a collaborative improvement network by a state affiliate of the American Society of Clinical Oncology. ( F1 )
Andrew Allan Hertler , MD, FACP - Harold Alfond Center for Cancer Care

Abstract # 88 : Enabling quality improvement in systemic cancer treatment through a collaborative approach. ( F10 )
Vicky Simanovski , B.MOS, MBA - Cancer Care Ontario

Abstract # 89 : Understanding and improving chemotherapy ordering and delivery using process elicitation and validation. ( F11 )
Wilson C. Mertens , MD - Baystate Regional Cancer Program

Abstract # 90 : Early recognition and treatment of febrile neutropenia in a community hospital. ( F12 )
Therese M. Mulvey , MD - Southcoast Hospitals Group

Abstract # 91 : Can equitable care eliminate colon cancer disparities? ( F13 )
Manali I. Patel , MD - Stanford University Medical Center

Abstract # 92 : Wait time reduction for patients awaiting chemotherapy infusion using a formal process improvement approach and sequential ( F14 )
Andrew David Norden , MD, MPH - Dana-Farber Cancer Institute

Abstract # 93 : Using a disease pathway management (DPM) approach to improve the quality of lung cancer care in Ontario. ( F15 )
William K. Evans , MD, FRCPC - McMaster University

Abstract # 94 : Morbidity, mortality, and improvement (MM&I) conference leading to change. ( F16 )
Andrew Jacob Moore , MD - Vanderbilt University Medical Center

Abstract # 95 : The use of a palliative care tool in a community private practice. ( F17 )
Tallat Mahmood , MD - Mid Michigan Physicians

Abstract # 96 : Patient retention and costs associated with a pancreatic multidisciplinary clinic. ( F18 )
Shereef M. Elnahal , MD, MBA - Department of Medicine, Brigham and Women's Hospital

Abstract # 80 : Raising the bar: Breast cancer biomarkers IHC4 harmonization from University of California-Athena pathology collaboration. ( F2 )
John W. Bishop , M.D. - Univeristy of California, Davis

Abstract # 81 : Securing discharge follow-up appointments in a women's cancer program. ( F3 )
Carole Dalby , CCRP,BSN,RN - Dana-Farber Cancer Institute

Abstract # 82 : Minimizing wait time between chemotherapy and radiotherapy treatments. ( F4 )
James J. Sauerbaum , BS - Abramson Cancer Center of the University of Pennsylvania

Abstract # 83 : Implementation of team training in outpatient breast oncology. ( F5 )
Craig A. Bunnell , MD - Dana-Farber Cancer Institute

Abstract # 84 : Improving infusion therapy efficiency at the Woodlands Regional Care Center. ( F6 )
Jeremy Meade , BSIE, MSIE - The University of Texas MD Anderson Cancer Center

Abstract # 85 : Prospective quality review of breast care navigation and treatment: Fox Chase Cancer Center Partners' (FCCCP) initiative. ( F7 )
Lori J. Goldstein , MD - Fox Chase Cancer Center

Abstract # 86 : Moving prevention of central line associated bloodstream infection efforts beyond the hospital walls: A multicenter pediatric hematology/oncology collaborative. ( F8 )
Amy Billett , MD - Dana-Farber Cancer Institute and Boston Children's Hospital, Pediatric Hematology/Oncology

Abstract # 87 : Community oncology care delivery staffing model. ( F9 )
David C. Fryefield , MD - The US Oncology Network

Abstract # 97 : The value of a genetic counselor for patient identification. ( G1 )
Jennifer N. Eichmeyer , MS, CGC - St. Luke's Mountain States Tumor Institute

Abstract # 106 : The prevalence and burden of cancer symptoms among underserved Chinese American patients. ( G10 )
Lara Dhingra , PhD - Beth Israel Medical Center

Abstract # 107 : Distress management in a community oncology center. ( G11 )
Lori Watts , MSW, LCSW - St. Luke's Mountain States Tumor Institute

Abstract # 108 : Attrition rates, reasons and predictive factors in supportive/palliative oncology clinical trials at a comprehensive cancer center. ( G12 )
Isabella Claudia Glitza , MD, PhD - The University of Texas MD Anderson Cancer Center

Abstract # 109 : Improving the quality of abstract reporting for economic analyses in oncology. ( G13 )
Maria Yi Ho , MD - British Columbia Cancer Agency Cancer Agency - Vancouver Centre

Abstract # 110 : Opportunities for better management of cancer in patients receiving chemotherapy at Aurora Health Care (AHC), a large integrated health system in eastern Wisconsin. ( G14 )
Paragkumar R. Amin , MD - Aurora Health Care

Abstract # 111 : Increasing genetics referrals: The National Cancer Institute Community Cancer Centers Program (NCCCP) network performance improvement project. ( G15 )
Jeffrey Cohn , MD, MHCM - Plexus Institute

Abstract # 112 : Evaluating survivorship cancer care through quality improvement programs. ( G16 )
Guadalupe R. Palos , RN, DrPH - The University of Texas MD Anderson Cancer Center

Abstract # 113 : The association between the transfer of emergency department boarders to inpatient hallways or off-service beds and the quality of oncology care. ( G17 )
Simron Singh , MD, MPH - Sunnybrook Health Sciences Centre, Odette Cancer Centre

Abstract # 114 : Unanticipated hospital admissions in patients undergoing radiotherapy with or without concurrent chemotherapy: Incidence and predictive factors. ( G18 )
Nabeel H. Arastu , B.S. - University of North Carolina at Chapel Hill and Brody School of Medicine at East Carolina University

Abstract # 98 : Improving detection of Lynch syndrome using a reflex immunohistochemistry algorithm for all patients with newly diagnosed colorectal cancer. ( G2 )
Minggui Pan , MD, PhD - Kaiser Permanente

Abstract # 99 : Improving patient safety by minimizing chemotherapy dosing errors. ( G3 )
Daniel McCrone , MD - New Century Health

Abstract # 100 : Evaluating systems of care. ( G4 )
Sarah Ford Duggan Goldstein , MPH - Blue Cross Blue Shield Association

Abstract # 101 : Elective chemotherapy admission pilot and work-flow improvements to reduce excess days. ( G5 )
Wendy Rowehl Miano , MSN, DNP, RN - University Hospitals Seidman Cancer Center

Abstract # 102 : Differential receipt of sentinel lymph node biopsy within practice-based research networks. ( G6 )
Anne-Marie Meyer , PhD - University of North Carolina at Chapel Hill

Abstract # 103 : Quality oversight for specialized cancer services. ( G7 )
Sherrie Hertz , BScPhm - Cancer Care Ontario

Abstract # 104 : Feasibility and savings of a suspicion of cancer clinic at a large county hospital. ( G8 )
Sarah Schellhorn Mougalian , MD - The University of Texas MD Anderson Cancer Center

Abstract # 105 : Outcome assessment of an oral chemotherapy management clinic: A preliminary report. ( G9 )
Siu-Fun Wong , PharmD - Loma Linda University School of Pharmacy

Abstract # 115 : Time to antibiotic. ( H1 )
Everett John Equila , BSN, RN - Kaiser Permanente

Abstract # 124 : A quality improvement program within the research setting to improve cancer clinical trial recruitment, accrual, and retention. ( H10 )
Margo Michaels , MPH - Education Network to Advance Cancer Clinical Trials

Abstract # 125 : Reducing time to initiation of colon cancer adjuvant chemotherapy in a large community-based hospital. ( H11 )
Karen Bochert , - Summa Health System

Abstract # 126 : Erlotinib patterns of use and out-of-pocket (OOP) expenses. ( H12 )
Jonas A. De Souza , M.D. - The University of Chicago Medicine

Abstract # 127 : Improvement of time to develop treatment plan at a specialized sarcoma center. ( H13 )
Adriana L. Chavez , PhD - The University of Texas MD Anderson Cancer Center

Abstract # 128 : Evaluation of inpatient cancer pain management at an academic medical center. ( H14 )
Michael Mearis , PharmD - University of Chicago Medicine

Abstract # 129 : Electronic medical records: Assessment of recorded cancer stage in support of quality of care. ( H15 )
Gregory P. Hess , MD, MBA, MSc - SDI, University of Pennsylvania

Abstract # 130 : Improving chemotherapy consent compliance. ( H16 )
Patricia D. Hegedus , RN, MBA,OCN - Spartanburg Regional Healthcare System

Abstract # 131 : Improving new patient access for patients with colorectal cancer. ( H17 )
Kathy Denton , PhD - The University of Texas MD Anderson Cancer Center

Abstract # 132 : Quality improvement for symptom control in underserved Chinese cancer patients. ( H18 )
Lara Dhingra , PhD - Beth Israel Medical Center

Abstract # 116 : Use of predictive models (PMs) in colorectal cancer (CRC) for diagnosis of Lynch syndrome (LS): A process measure for quality of care. ( H2 )
Sarmad Sadeghi , MD, PhD - None

Abstract # 117 : Implementation and evaluation of a tobacco cessation program in an outpatient oncology center. ( H3 )
Thomas A. Hensing , MD - NorthShore University HealthSystem

Abstract # 118 : Preliminary decision-tree analysis of costs to payors associated with a pancreatic multidisciplinary clinic. ( H4 )
Shereef M. Elnahal , MD, MBA - Department of Medicine, Brigham and Women's Hospital

Abstract # 119 : Chlorhexidine bathing to reduce CLABSI in hematopoietic stem cell transplant and hematologic malignancy patients. ( H5 )
Christina Reeber , RN, BSN, OCN - University Hospitals Seidman Cancer Center

Abstract # 120 : The incidence of acute kidney injury among children treated for fever and neutropenia after elimination of empiric gentamycin use. ( H6 )
Andras Heczey , MD - Baylor College of Medicine

Abstract # 121 : Supervised exercise for cancer survivors during and after active therapy. ( H7 )
Mark Allen O'Rourke , MD - Greenville Hospital System University Medical Center

Abstract # 122 : Building success in quality improvement: An analysis of what barriers hinder and what catalysts promote the widespread adoption of quality improvement initiatives. ( H8 )
William T. Sause , MD - Intermountain Healthcare

Abstract # 123 : Cancer therapy and heart failure: Successful management through collaborative interdisciplinary practice. ( H9 )
Anecita P. Fadol , PhD, RN, FNP-BC, FAANP - Department of Nursing - The University of Texas MD Anderson Cancer Center

Abstract # 133 : Sepsis in adult leukemia patients. ( I1 )
Jan Garza , RN, ANP-C, AOCNP - The University of Texas MD Anderson Cancer Center

Abstract # 142 : Understanding the drivers of cancer care at the regional, state, and local levels. ( I10 )
Ken Williams , - Avalere Health

Abstract # 143 : Quality improvement using lean methods to increase access and utilization of support services in younger breast cancer survivors. ( I11 )
Deborah Mayer , RN, PhD - University of North Carolina at Chapel Hill

Abstract # 144 : Off-shift administration operations improvement collaborative. ( I12 )
Angela Hayes-Rodgers , MBA - The University of Texas MD Anderson Cancer Center

Abstract # 145 : Caring for our deceased. ( I13 )
Kimberly Tripp , MBA, BSN, RN - The University of Texas MD Anderson Cancer Center

Abstract # 146 : Improving quality of early breast cancer care with a predictive test for taxane response. ( I14 )
Carolyn Bodnar , M.Sc - GE Healthcare

Abstract # 147 : Increasing hand hygiene compliance using a solution session. ( I15 )
Duke Rohe , BS, Eng - The University of Texas MD Anderson Cancer Center

Abstract # 148 : Improving VTE prophylaxis in hospitalized oncologic patients: Institutional impact VTE mentored QI project. ( I16 )
Josiah Halm , - The University of Texas MD Anderson Cancer Center

Abstract # 149 : Impact of early engagement of patients with clinical trial information in a system-based multidisciplinary breast cancer clinic on clinical trial enrollment. ( I17 )
Minggui Pan , MD, PhD - Kaiser Permanente

Abstract # 150 : Improving quality of care and reducing costs with angiogenesis-specific imaging tests in metastatic breast cancer. ( I18 )
Carolyn Bodnar , M.Sc - GE Healthcare

Abstract # 134 : Avoidance of futile treatment and adverse events by using angiogenesis-specific imaging for early detection of disease progression in patients with first-line metastatic renal cell carcinoma. ( I2 )
Stephen K. Gruschkus , PhD, MPH - Xcenda, LLC

Abstract # 135 : The role, use, and nuances of clinical data systems in oncology quality improvement. ( I3 )
Thomas Belnap , MS - Intermountain Healthcare

Abstract # 136 : Can we improve community adjuvant treatment reporting to a hospital tumor registry? ( I4 )
Nina Bickell , MD, MPH - Mount Sinai School of Medicine

Abstract # 137 : Norris Cotton Cancer Center (NCCC) neuro-oncology glioma tumor quality improvement project. ( I5 )
Evelyn Schlosser , MPH, MA, RN, CPHQ - Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center

Abstract # 138 : Breast imaging boot camp: A mammography quality improvement intiative. ( I6 )
Danielle Dupuy , MPH - Chicago Breast Cancer Quality Consortium

Abstract # 139 : Emerging development and use of clinical pathways to improve quality and standardize care in oncology. ( I7 )
Colin Nash , MHA - Avalere Health

Abstract # 140 : Systems engineering in health care: Overview and examples from the University of Texas M. D. Anderson Cancer Center. ( I8 )
Victoria S. Jordan , PhD, MS, MBA - The University of Texas MD Anderson Cancer Center

Abstract # 141 : Oncology quality improvement as a cornerstone of the transition to accountable care. ( I9 )
John C. Ruckdeschel , MD - Intermountain Healthcare

Abstract # 151 : The role of ACOs in accelerating high-quality care: Implications for prostate cancer. ( J1 )
Grant Picarillo , MS - Avalere Health

Abstract # 152 : Transitioning chemotherapy administration from the inpatient setting: Creating bed capacity and improving the patient experience. ( J2 )
Regina Cunningham , PhD, RN, AOCN - Penn Medicine

Abstract # 153 : Implementing independent double checks for patient-controlled analgesia (PCA) pump programming. ( J3 )
Nie Bohlen , RN, MSN - Massachusetts General Hospital

Abstract # 154 : Systematic improvement of SBRT dose gradients. ( J4 )
Patrick James Gagnon , MD, MS - Southcoast Centers for Cancer Care

Abstract # 155 : The LIVESTRONG essential elements of survivorship care: Advancing quality survivorship care in clinical care settings. ( J5 )
Sarah R. Arvey , PhD - Lance Armstrong Foundation

Abstract # 156 : Redesigning the transfer center process to adapt to increasing demands for services. ( J6 )
Pamela B. Douglas-Ntagha , RN, MSN, MBA, JD - The University of Texas MD Anderson Cancer Center

Abstract # 157 : Clinical process analysis. ( J7 )
Courtney Barnes , MBA - The University of Texas MD Anderson Cancer Center

Abstract # 158 : Value metrics of a nurse navigator patient support program within a multidisciplinary esophageal cancer clinic. ( J8 )
Helen J. Ross , MD - Mayo Clinic

Abstract # 159 : Quality improvement research in oncology: A bibliometric analysis. ( J9 )
Samir Mohamed Haq , MD - Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center

Abstract # 160 : Standardizing quality breast cancer care throughout all New York university facilities. ( K1 )
Anna C. Pavlick , MD - New York University School of Medicine and New York University Cancer Institute

Abstract # 161 : Efficacy of oral ketamine against opioid-refractory cancer pain due to bone metastases: Four case reports. ( K2 )
Takeshi Hagihara , - Osaka Red Cross Hospital

General Poster Session B

 

Quality Oncology Practice Initiative
Poster Boards: A7-B10 (Abstracts #165, 203, 206-209, 212, 226, 241, 261, 275, 328)

Radiation Oncology
Poster Boards: B11-C8 (Abstracts #64, 186, 187, 204, 205, 210, 211, 219, 266, 267, 300, 304)

Guideline Recommendation Compliance and Its Effects on Quality
Poster Boards: C9-E6 (Abstracts #162-202)

Quality Measurement
Poster Boards: E7-H11 (Abstracts #215-284)

The Use of IT to Improve Quality
Poster Boards: H12-K2 (Abstracts #288-330)

Abstract # 66 : Measuring the improving quality of outpatient care in medical oncology practices in the United States. ( A1 )
Michael N. Neuss , MD - Vanderbilt-Ingram Cancer Center

Abstract # 67 : Evolution of multidisciplinary care: Experience of the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP). ( A2 )
Eliot Lawrence Friedman , MD - Lehigh Valley Hospital and Health Network

Abstract # 68 : Use of a community of practice (CoP) platform as a model in regional quality improvements in cancer surgery: The Ottawa model. ( A3 )
Michael Fung-Kee-Fung , MBBS, FRCS, MBA - The Ottawa Hospital

Abstract # 73 : Rational use of intensity-modulated radiation therapy (IMRT) as determined by radiation oncologists in cooperation with Blue Cross Blue Shield of Massachusetts (BCBSMA). ( A4 )
Harvey J. Mamon , MD, PhD - Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital

Abstract # 214 : Concordance and disease type variables between adjuvant chemotherapy (AC) recommended and received as assessed by the Quality Oncology Practice Initiative (QOPI). ( A5 )
Joseph O. Jacobson , MD - Dana-Farber Cancer Institute

Abstract # 287 : Improving cancer care by linking community cancer center physicians to disease site-specific experts. ( A6 )
Patricia H. Hardenbergh , MD - Shaw Regional Cancer Center

Abstract # 165 : Toward proven and prioritized quality measures: Which ASCO QOPI and other supportive care measures associate with improved quality of life (QOL)? ( A7 )
Arif Kamal , MD - Duke Cancer Institute and Center for Learning Healthcare at Duke Clinical Research Institute

Abstract # 203 : Driving performance improvement using ASCO’s Quality Oncology Practice Initiative (QOPI). ( A8 )
Shelby Darland , RN, MSN - St. Luke's Mountain States Tumor Institute

Abstract # 206 : Quality improvement outcomes in an academic practice participating in ASCO's Quality Oncology Practice Initiative (QOPI). ( B1 )
Mary Anne Fenton , MD - Department of Medicine, Warren Alpert Medical School of Brown University

Abstract # 328 : Improving nurse practitioner documentation of QOPI symptom management and end-of-life care measures by using "smart text" in electronic health records. ( B10 )
Peg Esper , DNP(c), MSN, MSA, NP - University of Michigan Comprehensive Cancer Center

Abstract # 64 : Use of surgery and chemoradiation in stage II and III rectal cancer: A retrospective comparison of treatment modalities in major insurance types using the NCDB. ( B11 )
Mary Warlaumont , BA - Creighton University

Abstract # 186 : Evaluation of process control in radiation oncology treatment planning. ( B12 )
Henry Wagner , MD - Penn State Hershey Cancer Institute

Abstract # 187 : Categorization of measures of quality in radiation treatment. ( B13 )
Jeffrey Quoc Cao , MD, MBA, FRCPC - British Columbia Cancer Agency

Abstract # 204 : The negative impact of prior reprimand on radiation therapists' and dosimetrists' comfort in reporting errors: Results from a national survey of more than 500 respondents. ( B14 )
Jessica A. Church , MPH, RT(R)(T) - University of North Carolina Department of Radiation Oncology

Abstract # 207 : Capturing and addressing emotional well-being: Utilization of ASCO's Quality Oncology Practice Initiative (QOPI) for performance improvement. ( B2 )
Patricia D. Hegedus , RN, MBA,OCN - Spartanburg Regional Healthcare System

Abstract # 208 : Utilizing QOPI in the quality improvement efforts of the NCI Community Cancer Centers Program (NCCCP). ( B3 )
Robert D. Siegel , MD - Hartford Hospital-Helen and Harry Gray Cancer Center

Abstract # 209 : Persistence of quality improvement in a veterans affairs (VA) academic practice assessed by quality oncology practice initiative (QOPI). ( B4 )
Kathleen L. Kiernan , M.D. - Duke University Medical Center

Abstract # 212 : Improving quality of pediatric oncology care via ASCO's Quality Oncology Practice Initiative (QOPI) program. ( B5 )
Robert Michael Cooper , MD - Kaiser Permanente

Abstract # 226 : Physician inter-annotator agreement in the Quality Oncology Practice Initiative (QOPI) manual abstraction task. ( B6 )
Jeremy Warner , MD, MS - Vanderbilt University

Abstract # 241 : Using QOPI metrics for physician incentive compensation. ( B7 )
Grace Makari-Judson , MD - Baystate Medical Center

Abstract # 261 : Compliance to select quality measures in a non-QOPI subspecialty academic practice: A pilot quality improvement initiative. ( B8 )
Sonia Evelyn Reichert , MD - Mount Sinai School of Medicine

Abstract # 275 : Assessing quality in a rural oncology program using the Quality Oncology Practice Initiative (QOPI). ( B9 )
William S. Loui , MD, FACP - University of Hawaii Cancer Center

Abstract # 205 : Quantification of the impact of multifaceted improvements in patient safety culture: A case study from academic medical center radiation oncology department. ( C1 )
Bhishamjit S. Chera , MD - Department of Radiation Oncology, University of North Carolina at Chapel Hill

Abstract # 163 : Attitudes toward and use of cancer management guidelines in a national sample of medical oncologists and surgeons. ( C10 )
Grace Huang , - University of Michigan Medical School

Abstract # 164 : Quality of care among breast cancer (BC) survivors in the University of California (UC) Athena Breast Health Network. ( C11 )
Patricia A. Ganz , MD - UCLA's Jonsson Comprehensive Cancer Center

Abstract # 166 : Central reporting of human epidermal growth factor receptor-2 (HER2) status and adherence to testing and adjuvant trastuzumab treatment guidelines in Ontario. ( C12 )
Craig Earle , MD - Institute for Clinical Evaluative Sciences

Abstract # 167 : Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting (CINV) in U.S. community oncology practice: INSPIRE study. ( C13 )
James W. Gilmore , PharmD - Georgia Cancer Specialists

Abstract # 168 : Use of advanced imaging and biomarker tests for post-treatment surveillance in early-stage breast cancer survivors. ( C14 )
Erin E. Hahn , MPH - Division of Cancer Prevention and Control Research, University of California, Los Angeles

Abstract # 169 : Adherence to guidelines for adjuvant chemotherapy (AC) use in stage II colon cancer (CC). ( C15 )
Winson Y. Cheung , MD, MPH - British Columbia Cancer Agency

Abstract # 170 : Bridging efforts to longitudinally improve and evaluate venous thromboembolism prophylaxis uptake in hospitalized cancer patients through interprofessional teamwork (BELIEVE IT): a study by princess margaret cancer centre. ( C16 )
Jack Toshimine Seki , PharmD, University of Toronto - Princess Margaret Cancer Centre

Abstract # 171 : Guideline-concordant surveillance and follow-up care among low-income patients with breast cancer: The role of primary care medical homes. ( C17 )
Stephanie B. Wheeler , PhD - University of North Carolina at Chapel Hill

Abstract # 172 : Opportunities for improvement (OFI) in guideline concordance (GLC) at National Comprehensive Cancer Network (NCCN) member institutions (MI). ( C18 )
Jennifer Lyle , MA - National Comprehensive Cancer Network

Abstract # 173 : Socioeconomic and clinical factors associated with delayed initiation of adjuvant chemotherapy for stage III colon cancer. ( C19 )
Alex Bernard Haynes , MD, MPH - The University of Texas MD Anderson Cancer Center

Abstract # 210 : Predictors of quality radiation therapy completion after breast-conserving surgery. ( C2 )
Benjamin Daniel Powers , M.D. - Temple University School of Medicine

Abstract # 174 : Rates of bone mineral density measurement in men with prostate cancer starting androgen deprivation therapy. ( C20 )
Maria Suarez-Almazor , MD, PhD - The University of Texas MD Anderson Cancer Center

Abstract # 211 : Peer-review of radiation treatment planning in a provincial radiation oncology program: A survey of current practice. ( C3 )
Thomas S. McGowan , MD - Credit Valley Hospital

Abstract # 219 : Variation in the use of intensity-modulated radiation therapy (IMRT) in the state of Michigan: 2005-2010. ( C4 )
James Hayman , MD - Department of Radiation Oncology, University of Michigan Health System

Abstract # 266 : The Canadian partnership for quality radiotherapy: A model for radiation treatment quality and safety. ( C5 )
Jeffrey Quoc Cao , MD, MBA, FRCPC - British Columbia Cancer Agency

Abstract # 267 : National Radiation Oncology Registry: The pilot prostate cancer registry. ( C6 )
Jason Alexander Efstathiou , MD, DPhil - Massachusetts General Hospital

Abstract # 300 : Developing an IT infrastructure for the National Radiation Oncology Registry. ( C7 )
Todd McNutt , PhD - Johns Hopkins University School of Medicine

Abstract # 304 : Radiation oncology whiteboard: Data and workflow manager for enhanced communication and task management. ( C8 )
John A. Wolfgang , PhD - Massachusetts General Hospital

Abstract # 162 : Use of survivorship care plans to re-engineer breast cancer follow-up. ( C9 )
Grace Makari-Judson , MD - Baystate Medical Center

Abstract # 175 : Effect of national recommendations on hepatitis B virus screening in a large U.S. cancer center. ( D1 )
Jessica Hwang , MD, MPH - The University of Texas MD Anderson Cancer Center

Abstract # 184 : Skin cancer surveillance and malignancies in patients with chronic lymphocytic leukemia (CLL). ( D10 )
Aaron Scott Mansfield , MD - Mayo Clinic

Abstract # 185 : Reducing unnecessary testing on admission in autologous stem cell transplant (SCT) patients. ( D11 )
Brett Glotzbecker , MD - Dana-Farber Cancer Institute

Abstract # 188 : Primary care providers evaluation of survivorship care plans. ( D12 )
Deborah Mayer , RN, PhD - University of North Carolina at Chapel Hill

Abstract # 189 : Compliance with established pneumonia core measures at M. D. Anderson Cancer Center in the emergency center. ( D13 )
Carmen E. Gonzalez , MD - The University of Texas MD Anderson Cancer Center

Abstract # 190 : Does a quality-of-care problem exist? Cancer Care Ontario practice pattern data and the recommendations of two lung cancer practice guidelines. ( D14 )
Melissa C. Brouwers , PhD - McMaster University

Abstract # 191 : De-adoption of epidermal growth factor receptor (EGFR) inhibitors following recommendations for KRAS testing to guide treatment of metastatic colorectal cancer (mCRC). ( D15 )
Efrat Dotan , MD - Fox Chase Cancer Center

Abstract # 192 : Implementing patient-centered care: Challenges in community oncology. ( D16 )
Kathleen Clifford , MSN, FNP-BC, AOCNP, ACHPN - St. Luke's Mountain States Tumor Institute

Abstract # 193 : Adherence to head and neck cancer guidelines: Setting the stage for continual quality improvement. ( D17 )
Zhannat Nurgalieva , MD, MPH - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center

Abstract # 194 : Evaluating the impact of a clinical universal mismatch repair screening initiative. ( D18 )
Michael J. Hall , MD, MS - Fox Chase Cancer Center

Abstract # 195 : Investigation of gastrointestinal stromal tumor (GIST) care management in GIST patients (pts) receiving short-term versus long-term imatinib (IM) adjuvant therapy: A chart review analysis. ( D19 )
Anthony Paul Conley , MD - H. Lee Moffitt Cancer Canter & Research Institute

Abstract # 176 : Feasibility of screening hospitalized patients for palliative care. ( D2 )
Paul A. Glare , MBBS - Memorial Sloan-Kettering Cancer Center

Abstract # 177 : Use of a Pan-Canadian indicator to measure treatment rates relative to evidence-based guidelines for rectal cancer. ( D3 )
Tonia Forte , MSc - Canadian Partnership Against Cancer

Abstract # 178 : Compliance with NCCN guidelines in the management of extra-abdominal soft tissue sarcoma across the United States. ( D4 )
Nabil Wasif , MD - Mayo Clinic

Abstract # 179 : Chemotherapy safe handling and safe labeling guideline concordance evaluation: A Canadian experience. ( D5 )
Kathy Vu , PharmD - Cancer Care Ontario, University of Toronto

Abstract # 180 : The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer. ( D6 )
Yvonne Sada , MD - Michael E. DeBakey Veterans Affairs Medical Center

Abstract # 181 : Radiotherapy protocol deviations and clinical outcomes: A meta-analysis of cooperative group clinical trials. ( D7 )
Nitin Ohri , MD - Department of Radiation Oncology, Albert Einstein College of Medicine and Montefiore Medical Center

Abstract # 182 : Erlotinib and patterns of pharmacogenomic (PGx) testing. ( D8 )
Jonas A. De Souza , M.D. - The University of Chicago Medicine

Abstract # 183 : Safe chemotherapy: Clinicians driving technology and not the other way around. ( D9 )
Vishal Kukreti , MD, MSc, FRCPC - Cancer Care Ontario

Abstract # 197 : Prospective synoptic template recording to assess for compliance of care with NCCN guidelines for breast cancer. ( E1 )
Titilayo Adegboyega , MD - Gundersen Lutheran Medical Center

Abstract # 218 : National evaluation of the VA’s quality of supportive care. ( E10 )
Anne M. Walling , MD, PhD - VA Greater Los Angeles Healthcare System

Abstract # 220 : Monitoring acute care utilization (ACU) during adjuvant chemotherapy for early breast cancer (EBC) as a measure of quality. ( E11 )
Katherine Enright , MD MPH - The Carlo Fidani Peel Regional Cancer Centre, Credit Valley Hospital

Abstract # 221 : Chemotherapy dose selection in a diverse sample of medically underserved women with breast cancer. ( E12 )
Jennifer J. Griggs , MD, MPH - University of Michigan

Abstract # 222 : Receipt of guideline-concordant treatment in elderly African American and Caucasian patients with prostate cancer. ( E13 )
Ronald C. Chen , MD, MPH - University of North Carolina at Chapel Hill

Abstract # 223 : Use of performance data to drive process change and improve patient wait time for chemotherapy treatment. ( E14 )
Ben De Mendonca , - Sunnybrook Health Sciences Centre, Odette Cancer Centre

Abstract # 225 : Impact on mortality of increasing surgical volumes within hospitals after regionalization of thoracic surgery in Ontario, Canada. ( E16 )
Anna Bendzsak , MD, MHSc, FRCSC - University of Toronto, Department of Surgery, Division of Thoracic Surgery, Institute of Medical Sciences

Abstract # 227 : Impact of a cancer management program. ( E17 )
J. Russell Hoverman , MD, PhD - Texas Oncology, The US Oncology Network

Abstract # 228 : Quality of adjuvant chemotherapy in stage III colon cancer. ( E18 )
Monika K. Krzyzanowska , MD, MPH, FRCPC - Cancer Care Ontario

Abstract # 229 : Examining potential cancer care disparities in an equal access system: Quality of colorectal cancer care (CRC) in the Veterans Affairs (VA) health care system. ( E19 )
Leah L. Zullig , MPH - Health Services Research and Development, Durham Veteran Affairs Medical Center

Abstract # 198 : Treatment patterns of castration-resistant prostate cancer: A retrospective claims database analysis. ( E2 )
Tanya Burton , PhD - OptumInsight

Abstract # 230 : Claims/utilization-based intensity of end-of-life (EOL) cancer care in integrated health systems (IHS). ( E20 )
Elizabeth Loggers , MD, PhD - Group Health Research Institute

Abstract # 199 : Chronic hepatitis B virus screening prior to rituximab: A quality improvement project. ( E3 )
Raina Mahajan , MD - Georgetown University; Washington Hospital Center

Abstract # 200 : Impact of a multidisciplinary cancer care program and nurse navigation on pancreatic adenocarcinoma treatment. ( E4 )
Laurence E. McCahill , MD - The Lacks Cancer Center at Saint Mary's

Abstract # 201 : Predictors of failure to perform pelvic peritoneal cytology in endometrial cancer staging surgery. ( E5 )
Micael Lopez-Acevedo , MD - Duke University Medical Center

Abstract # 202 : Adherence to head and neck cancer guidelines: Multidisciplinary conference recommendations and care delivered. ( E6 )
Zhannat Nurgalieva , MD, MPH - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center

Abstract # 215 : Targeted agent use in patients with cancer at the end of life. ( E7 )
David Hui , MD, MSc, FRCPC - The University of Texas MD Anderson Cancer Center

Abstract # 216 : Patient safety in Danish cancer care: Results from complementary studies. ( E8 )
Janne Lehmann Knudsen , MD, PhD - The Danish Cancer Society

Abstract # 217 : The effect of care at NCI comprehensive cancer centers on disparities in outcome in adolescents and young adults (AYAs) with cancer. ( E9 )
Julie Anna Wolfson , MD, MSHS - City of Hope

Abstract # 231 : Chemotherapy use during the last 30 days of life in patients with cancer. ( F1 )
Maria Alma Rodriguez , MD - The University of Texas MD Anderson Cancer Center

Abstract # 240 : An analytic framework for capturing trends in utilization, costs, and quality metrics in cancer patients’ last 6 months of life. ( F10 )
Brian Cassel , PhD - VCU Massey Cancer Center

Abstract # 242 : Use of diagnostic testing for patients with early-stage breast cancer in a multi-hospital quality collaborative in Michigan. ( F11 )
Tara M. Breslin , MD, FACS - University of Michigan Comprehensive Cancer Center

Abstract # 243 : Analysis of stage of melanoma diagnosis in relation to insurance type and income as an indicator of early/late diagnosis. ( F12 )
Peter Makram Lamie , DO - Creighton University

Abstract # 244 : Staging documentation accuracy and adherence to workup and treatment guidelines: The M. D. Anderson Regional Care Center experience. ( F13 )
Amitabha Sarma , MD - The University of Texas MD Anderson Cancer Center, Regional Care Center Sugar Land

Abstract # 245 : Quantification of physician workload for radiotherapy planning, and possible associations with performance. ( F14 )
Lukasz M. Mazur , PhD - Deparmtent of Radiation Oncology - University of North Carolina at Chapel Hill

Abstract # 246 : Using quality indicators to monitor changes in adherence to clinical practice guidelines for treatment of ductal carcinoma in situ (DCIS) of the breast. ( F15 )
Laura Chin-Lenn , MBBS - University of Calgary

Abstract # 247 : 30 day all-cause readmission rate at a cancer center is not a quality of care measure. ( F16 )
Ronald Stewart Walters , MD, MHS, MS, MBA - The University of Texas MD Anderson Cancer Center

Abstract # 248 : Development of quality indicators for treatment of ductal carcinoma in situ (DCIS) of the breast using a multidisciplinary delphi process. ( F17 )
May Lynn Quan , MD, MSc - Foothills Medical Centre

Abstract # 249 : Quality of systemic cancer therapy in routine care: What are we measuring? ( F18 )
Shixin (Cindy) Shen , MD candidate, MPH, BSc - Faculty of Medicine, University of Toronto

Abstract # 232 : Impact of race on early-stage lung cancer treatment and survival. ( F2 )
Christina D. Williams , PhD - Durham VA Medical Center; Duke University Medical Center

Abstract # 233 : Patient-centered wait time measurement in Ontario. ( F3 )
Leonard Kaizer , MD - Cancer Care Ontario

Abstract # 234 : Retrospective assessment of quality of cancer care in last 6 months of life. ( F4 )
Brian Cassel , PhD - VCU Massey Cancer Center

Abstract # 235 : Measuring adverse event rates in oncology inpatients using trigger tools: An assessment of measurement properties. ( F5 )
Thea Otto Mattsson , MD - Odense University Hospital, Department of Oncology

Abstract # 236 : Measuring patient satisfaction in oncology. ( F6 )
Joseph Rodgers Steele , MD MMM - The University of Texas MD Anderson Cancer Center

Abstract # 237 : Frequency of physician misconceptions that may drive underuse of radiotherapy (RT) in patients with breast cancer. ( F7 )
Jessica Zhou , MD - University of Michigan

Abstract # 238 : Uncertainty in the management of thyroid cancer. ( F8 )
Megan Haymart , MD - University of Michigan

Abstract # 239 : The value of a quality metric. ( F9 )
J. Russell Hoverman , MD, PhD - Texas Oncology

Abstract # 250 : The psychosocial matrix: A community-derived evaluative tool for designing quality psychosocial cancer care. ( G1 )
Laura Pence Forsythe , PhD, MPH - National Cancer Institute

Abstract # 259 : The evolution of supportive care quality measures portfolio and conformance. ( G10 )
Ryan David Nipp , MD - Department of Medicine, Duke University Medical Center

Abstract # 260 : Assessment of the effectiveness of a pre-chemotherapy teaching session: A Brown University Oncology Group study. ( G11 )
Nathan Connell , MD - Brown University Oncology Group

Abstract # 262 : Treatment trends for stage III non-small cell lung cancer for noninsured patients compared with other types of insurances: A National Cancer Database analysis. ( G12 )
Khaled Abou El Ezz , M.D. - Creighton University Medical Center

Abstract # 263 : A self-assessment tool for safety and quality improvement in radiotherapy. ( G13 )
Todd Pawlicki , PhD, FAAPM - University of California, San Diego

Abstract # 264 : Development of quality indicators for women at high risk for breast cancer. ( G14 )
Armin Shahrokni , MD,MPH - University of California, Los Angeles, Medical Center

Abstract # 265 : Where you stand depends on where you sit: Alignment of quality measures to strategic intentions. ( G15 )
David M. Dilts , PhD, MBA - Oregon Health & Science University

Abstract # 268 : “Stop smoking!” Do we say It enough? ( G16 )
Jessica Ann Reifer Hildebrand , MD - New Hanover Regional Medical Center

Abstract # 270 : Aligning cancer quality metrics across the continuum of community-based and academic medicine using a prioritization tool. ( G18 )
Lisa M. Kidin , BSN,MHA,MSN - Office of Performance Improvement, The University of Texas MD Anderson Cancer Center

Abstract # 271 : Method of biopsy and sample quality for genetic mutation testing in advanced non-small cell lung cancer in a community hospital. ( G19 )
Borys Hrinczenko , MD, PhD - MSU Breslin Cancer Center

Abstract # 251 : Causes of chemotherapy infusion delays: Results of a time study in an academic cancer clinic in the community. ( G2 )
Ivy Altomare , MD - Duke University Medical Center

Abstract # 272 : Coordination and timeliness of care by insurance status in a gastrointestinal (GI) multidisciplinary care (MDC) program. ( G20 )
Laurence E. McCahill , MD - The Lacks Cancer Center at Saint Mary's

Abstract # 252 : Using a pathways process to ensure measurable evidence-based standardized care in a large cancer network. ( G3 )
Peter G. Ellis , MD - UPMC Cancer Centers

Abstract # 253 : The oncology palliative care matrix: A community-derived evaluation tool for constructing oncology palliative care programs. ( G4 )
Lynne Padgett , PhD - National Cancer Institute

Abstract # 254 : Measuring and reporting on system performance across the Canadian cancer control continuum. ( G5 )
Rami Rahal , B.Sc., MBA - Canadian Partnership Against Cancer

Abstract # 255 : Identification, categorization, and mapping of indicators used by JACIE-accredited stem cell transplantation programs to assess distribution and coverage of processes. ( G6 )
Caunday Olivia , - CHU de Nancy Brabois

Abstract # 256 : Patterns and predictors of chemotherapy and trastuzumab use for early-stage breast cancer in Kaiser Permanente Northern California, 2004-2007. ( G7 )
Allison W. Kurian , MD, MSc - Stanford University

Abstract # 257 : A comparison of chemotherapy use in stage IV pancreatic cancer. ( G8 )
Naomi Whittaker , M4 - Creighton University

Abstract # 258 : From evidence to impact: Determining the vital few indicators for systemic treatment computerized prescriber order entry systems (ST CPOE). ( G9 )
Sara Lankshear , RN PhD - Cancer Care Ontario

Abstract # 273 : Development of an evidence-based, patient-centered breast cancer chemotherapy and survivorship quality measures (QM) by the Oncology Nursing Society (ONS). ( H1 )
Kristen Fessele , RN, MSN - Oncology Nursing Society

Abstract # 283 : Ongoing professional practice evaluation implementation within STATIT. ( H10 )
Weiming Shi , MD - The University of Texas MD Anderson Cancer Center

Abstract # 284 : Single-institution evaluation of intrafraction motion during frameless stereotactic radiosurgery. ( H11 )
Kristin Kowalchik , MD, MS - Mayo Clinic

Abstract # 288 : Telehealth for oncology genetic counseling: An Idaho experience. ( H12 )
Jennifer N. Eichmeyer , MS, CGC - St. Luke's Mountain States Tumor Institute

Abstract # 289 : Use of electronic medical records on cancer screening rates: The proactive office encounter. ( H13 )
Joanne E. Schottinger , MD - Southern California Permanente Medical Group

Abstract # 290 : The use of technology to improve the delivery process of ambulatory chemotherapy at the Odette Cancer Centre (OCC). ( H14 )
Maureen E. Trudeau , MD, FRCPC - Sunnybrook Health Sciences Centre, Odette Cancer Centre

Abstract # 291 : Development of an electronic point-of-care quality monitoring system for palliative care. ( H15 )
Arif Kamal , MD - Duke Cancer Institute and Center for Learning Healthcare at Duke Clinical Research Institute

Abstract # 292 : Use of an electronic health record to improve follow-up of elevated lab results: The PSA safety net. ( H16 )
Kim N. Danforth , ScD,MPH - Kaiser Permanente Southern California

Abstract # 293 : Comprehensive stem cell transplant (SCT) outcome data submission. ( H17 )
Roy B. Jones , MD, PhD - The University of Texas MD Anderson Cancer Center

Abstract # 294 : Clinical decision support to improve quality and practice efficiency across a large network of oncology practices. ( H18 )
Debra A. Patt , MD, MPH - Texas Oncology

Abstract # 295 : Impact of computerized provider order entry on medication errors in outpatient chemotherapy administration. ( H19 )
Lyudmila Bazhenova , MD - University of California, San Diego Moores Cancer Center

Abstract # 274 : Postoperative complications as a predictor of 30-day hospital readmission following gastrointestinal cancer surgery. ( H2 )
Laurence E. McCahill , MD - The Lacks Cancer Center at Saint Mary's

Abstract # 296 : An automated system for insuring monitoring of myelosuppression in patients receiving self-administered oral chemotherapy. ( H20 )
Robert Morrell , MBA - Wake Forest School of Medicine

Abstract # 276 : Matching physician resources with demand in a cancer hospital emergency center. ( H3 )
John Allen Terrell , MS - The University of Texas MD Anderson Cancer Center

Abstract # 277 : MD Anderson Cancer Center Ongoing Professional Practice Evaluation (OPPE): We can see clearly now. ( H4 )
Joyce Roquemore , MBA, CPHQ - The University of Texas MD Anderson Cancer Center

Abstract # 278 : Average breast cancer stage in patients with various insurances and incomes. ( H5 )
Sehr Haroon , MD - Creighton University Internal Medicine

Abstract # 279 : Statistical methods as a problem-solving strategy in health care. ( H6 )
Diane Schaub , PhD, CQE - The University of Texas MD Anderson Cancer Center

Abstract # 280 : Public reporting outcomes of multidisciplinary cancer care: Conceptual issues. ( H7 )
James Austin Talcott , MD, SM - Continuum Cancer Centers of New York

Abstract # 281 : Use of palliative care measures to support improved patient outcomes and quality of life. ( H8 )
Ken Williams , - Avalere Health

Abstract # 282 : Timeliness of adjuvant chemotherapy (AT) for stage III adenocarcinoma of colon (CC): A measure of quality of care. ( H9 )
Steven Yu , MD - University of Southern California/LAC+USC Medical Center

Abstract # 297 : Automated telephone reminders: Potential to improve adherence to adjuvant hormonal therapy among patients with breast cancer. ( I1 )
Virginia P. Quinn , PhD, MPH - Kaiser Permanente Southern California

Abstract # 308 : Building platforms for collaborative care and clinical research in testicular cancer (TC): New approaches for care delivery for a model neoplasm. ( I10 )
Craig R. Nichols , MD - Testicular Cancer Commons

Abstract # 309 : The role of electronic records in reporting adverse drug reactions. ( I11 )
Alanna M. Poirier , MS - Cancer Treatment Centers of America at Midwestern Regional Medical Center

Abstract # 310 : Quality-of-care implications of improving physician communication through a Web-based tool (Teamwork). ( I12 )
Alex Pimenta Silva , MD - Clinica AMO - Assistência Multidisciplinar em Oncologia

Abstract # 311 : Medical informatics: Documenting quality of end-of-life, oncologic care. ( I13 )
Jennifer Carrie Obel , MD - NorthShore University HealthSystem

Abstract # 312 : The “Big 6 Spotlight”: Baseline assessment and implementation of a process to systematically collect critical oncology data elements for quality improvement and research. ( I14 )
Edward C. Li , - University of New England

Abstract # 313 : Information technology transforming quality of cancer care in developing nation. ( I15 )
Rakesh Roy , MD, ECMO, Dip Pall Med (UK) - Cancer Centre Welfare Home now known as Saroj Gupta Cancer Centre & Research Institute

Abstract # 314 : How to integrate vital interdisciplinary information in a non-closed-loop system? ( I16 )
Jack Toshimine Seki , PharmD, University of Toronto - Princess Margaret Cancer Centre

Abstract # 315 : Combining Web-based educational tools and mobile apps. ( I17 )
Vishal Kukreti , MD, MSc, FRCPC - Cancer Care Ontario

Abstract # 316 : Patient identification and tracking for chemotherapy delivery: Use of RFID or barcode technologies for automated self check-in. ( I18 )
Matthew C. Cheung , MD, SM - Sunnybrook Odette Cancer Centre

Abstract # 317 : Using mobile app technology for patient data capture and implementation. ( I19 )
Steven J. Nurkin , MD - Roswell Park Cancer Institute

Abstract # 298 : Short-term outcomes of implementation of computer-based breast cancer risk assessment program during screening mammography. ( I2 )
Debra M. Ray , MD - Leon Hess Cancer Center and Jacqueline M. Wilentz Comprehensive Breast Center at Monmouth Medical Center

Abstract # 318 : Use of online Internet resources by patients with cancer: The Canadian experience. ( I20 )
Lawson Eng , Hon BSc - Princess Margaret Hospital, University of Toronto

Abstract # 299 : Using computerized chemotherapy ordering to improve performance and documentation of informed consent. ( I3 )
James F. Brandman , MD, MS - Feinberg School of Medicine, Northwestern University

Abstract # 301 : Implementation of a visual appointment system to enhance oncology infusion suite efficiency at Norris Cotton Cancer Center (NCCC). ( I4 )
Evelyn Schlosser , MPH, MA, RN, CPHQ - Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center

Abstract # 302 : Using the electronic medical record to identify and follow survivors of pediatric malignancies. ( I5 )
Elizabeth Bell , RN - Southern California Permanente Medical Group

Abstract # 303 : An electronic chemotherapy administration safety checklist: The safe transition from paper to computer. ( I6 )
MiKaela M. Olsen , MS, RN, AOCNS - Johns Hopkins Hospital

Abstract # 305 : The power of knowledge: Sharing patient test results electronically to improve quality of care. ( I7 )
Melissa Kaan , BSc, MRT(NM), MBA - Cancer Care Ontario

Abstract # 306 : SAGE directory of cancer guidelines. ( I8 )
Melissa C. Brouwers , PhD - McMaster University

Abstract # 307 : Documentation of code status at an outpatient academic cancer center: A marker of discussing end-of-life preferences. ( I9 )
Anjana Ranganathan , MD - University of Pennsylvania

Abstract # 319 : Use of iPad technology to determine cancer patient- reported preferences for and understanding of pharmacogenetic testing (PGT). ( J1 )
Petra Martin , MD - Princess Margaret Hospital

Abstract # 320 : Utilization of a virtual collaboration portal to improve communication, education, and quality of care across a network of practices. ( J2 )
Jennifer Trageser , - The US Oncology Network/ McKesson Specialty Health

Abstract # 321 : Reducing variability in operating room utilization. ( J3 )
Craig S. Owen , BBA, CPHIMS - The University of Texas MD Anderson Cancer Center

Abstract # 322 : Using information technology to improve cancer care. ( J4 )
Amy Tarnower , MD - University of New Mexico

Abstract # 323 : Implementation of electronic chemotherapy ordering: An opportunity to improve evidence-based oncology care. ( J5 )
Kerin Adelson , MD - Mount Sinai School of Medicine

Abstract # 324 : Prevalence of overweight and obesity in a population of childhood leukemia patients and survivors. ( J6 )
Jennifer Lyn Jordan , RD, CSP - Kaiser Permanente Los Angeles Medical Center

Abstract # 325 : Development of a “virtual” multidisciplinary lung cancer tumor board in a community setting. ( J7 )
Marvaretta Miesha Stevenson , MD - Duke University Medical Center

Abstract # 326 : A shared decision support system for localized prostate cancer. ( J8 )
Pavan Dadlani , PDEng. - Philips Research

Abstract # 327 : Selection of medical oncology electronic medical record (EMR): A case study. ( J9 )
Josie McMurtrey , Solutions Development Analyst - Ascension Health Information Services/Saint Joseph Regional Medical Center

Abstract # 329 : The Pink Ribbon Survivors Network: An Internet resource for breast cancer survivorship education for patients and the health care providers that care for them. ( K1 )
Robert E. Fisher , MD - Rocky Mountain Cancer Centers, Longmont

Abstract # 330 : Pharmacy inventory control ordering web application. ( K2 )
Dalia Sumaida , MS, SSMBB - The University of Texas MD Anderson Cancer Center